Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment

Abstract

Drug resistance is a major challenge in cancer therapy that often leads to treatment failure and disease relapse. Despite advancements in chemotherapeutic agents and targeted therapies, cancers often develop drug resistance, making these treatments ineffective. Extracellular vesicles (EVs) have gained attention for their potential applications in drug delivery because of their natural origin, biocompatibility, and ability to cross biological barriers. Using the unique properties of EVs could enhance drug accumulation at target sites, minimize systemic toxicity, and precisely target specific cells. Here, we discuss the characteristics and functionalization of EVs, the mechanisms of drug resistance, and the applications of engineered EVs to overcome drug resistance. This review provides a comprehensive overview of the advancements in EV-based drug delivery systems and their applications in overcoming cancer drug resistance. We highlight the potential of EV-based drug delivery systems to revolutionize cancer therapy and offer promising strategies for more effective treatment modalities.

Keywords

Extracellular vesicles / drug delivery systems / drug resistance / tumor microenvironment / cancer therapy

References

[1] Bukowski K,Kontek R.Mechanisms of multidrug resistance in cancer chemotherapy.Int J Mol Sci2020;21:3233 PMCID:PMC7247559

[2] Gottesman MM,Bates SE.Multidrug resistance in cancer: role of ATP-dependent transporters.Nat Rev Cancer2002;2:48-58

[3] Ward RA,Floc'h N,McKerrecher D.Challenges and opportunities in cancer drug resistance.Chem Rev2021;121:3297-351

[4] Roberts AW,Huang DCS.BCL2 and MCL1 inhibitors for hematologic malignancies.Blood2021;138:1120-36

[5] Vogel A,Stenzinger A.FGFR2 inhibition in cholangiocarcinoma.Annu Rev Med2023;74:293-306

[6] Xiang S.Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib.Acta Pharm Sin B2024;14:517-32 PMCID:PMC10840435

[7] Xiong L,Jia Q.The application of extracellular vesicles in colorectal cancer metastasis and drug resistance: recent advances and trends.J Nanobiotechnology2023;21:143 PMCID:PMC10148416

[8] Welsh JA, Goberdhan DCI, O'Driscoll L, et al; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 2024;13:e12404. PMCID:PMC10850029

[9] Li SR,Gao X.Tissue-derived extracellular vesicles in cancers and non-cancer diseases: present and future.J Extracell Vesicles2021;10:e12175 PMCID:PMC8678102

[10] Li M,Sun M,Hu M.Extracellular vesicles as bioactive nanotherapeutics: an emerging paradigm for regenerative medicine.Theranostics2022;12:4879-903 PMCID:PMC9274746

[11] Du S,Xie A.Extracellular vesicles: a rising star for therapeutics and drug delivery.J Nanobiotechnology2023;21:231 PMCID:PMC10360328

[12] Dixson AC,Di Vizio D.Context-specific regulation of extracellular vesicle biogenesis and cargo selection.Nat Rev Mol Cell Biol2023;24:454-76 PMCID:PMC10330318

[13] Ming-Kun C,Mao-Ping C,Zhuang-Fei C.Engineered extracellular vesicles: a new approach for targeted therapy of tumors and overcoming drug resistance.Cancer Commun2024;44:205-25 PMCID:PMC10876209

[14] Rädler J,Zickler A.Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading.Mol Ther2023;31:1231-50 PMCID:PMC10188647

[15] Luo R,Tan T.Emerging significance and therapeutic potential of extracellular vesicles.Int J Biol Sci2021;17:2476-86 PMCID:PMC8315015

[16] Yang Q,Gu J.Extracellular vesicles in cancer drug resistance: roles, mechanisms, and implications.Adv Sci2022;9:e2201609 PMCID:PMC9731723

[17] Shan C,Wang K.Mesenchymal stem cell-derived extracellular vesicles in cancer therapy resistance: from biology to clinical opportunity.Int J Biol Sci2024;20:347-66 PMCID:PMC10750277

[18] Liu X,Yu T.CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy.Int J Biol Macromol2023;250:126147

[19] Lou G,Yang F.Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.J Hematol Oncol2015;8:122 PMCID:PMC4627430

[20] Zhang Q,Ning T.Exosome-delivered c-met siRNA could reverse chemoresistance to cisplatin in gastric cancer.Int J Nanomedicine2020;15:2323-35 PMCID:PMC7133545

[21] Liang Y,Lu J.Engineering exosomes for targeted drug delivery.Theranostics2021;11:3183-95 PMCID:PMC7847680

[22] Wen J,Liao C.Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells.Cancer Lett2023;575:216407

[23] Jia G,An Y.NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo.Biomaterials2018;178:302-16

[24] Pan BT,Wu C,Johnstone RM.Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes.J Cell Biol1985;101:942-8 PMCID:PMC2113705

[25] Dai W,Han T.Microenvironmental cue-regulated exosomes as therapeutic strategies for improving chronic wound healing.NPG Asia Mater2022;14:419

[26] Onukwugha NE,Nagrath S.Emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology: from target specific isolations to immunomodulation.Lab Chip2022;22:3314-39 PMCID:PMC9474625

[27] Panagopoulou MS,Birch DJS.Phenotypic analysis of extracellular vesicles: a review on the applications of fluorescence.J Extracell Vesicles2020;9:1710020 PMCID:PMC6968689

[28] Imanbekova M,Lu Y,Wachsmann-Hogiu S.Recent advances in optical label-free characterization of extracellular vesicles.Nanophotonics2022;11:2827-63 PMCID:PMC9128385

[29] Kolenc A.Current methods for analysing mesenchymal stem cell-derived extracellular vesicles.Int J Mol Sci2024;25:3439 PMCID:PMC10970230

[30] Wei H,Wang S.A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro.Int J Nanomedicine2019;14:8603-10 PMCID:PMC6830377

[31] Wu Y,Klinke DJ 2nd.Exosomes: improved methods to characterize their morphology, RNA content, and surface protein biomarkers.Analyst2015;140:6631-42 PMCID:PMC4986832

[32] Welsh JA,Bremer M.A compendium of single extracellular vesicle flow cytometry.J Extracell Vesicles2023;12:e12299 PMCID:PMC9911638

[33] Pospichalova V,Dave Z.Simplified protocol for flow cytometry analysis of fluorescently labeled exosomes and microvesicles using dedicated flow cytometer.J Extracell Vesicles2015;4:25530 PMCID:PMC4382613

[34] Bağcı C,Belder N,Erdener ŞE.Overview of extracellular vesicle characterization techniques and introduction to combined reflectance and fluorescence confocal microscopy to distinguish extracellular vesicle subpopulations.Neurophotonics2022;9:021903 PMCID:PMC8978261

[35] Wang JM,Wu JY.Comparative evaluation of methods for isolating small extracellular vesicles derived from pancreatic cancer cells.Cell Biosci2021;11:37 PMCID:PMC7877077

[36] Teixeira-Marques A,Montezuma D.Improved recovery of urinary small extracellular vesicles by differential ultracentrifugation.Sci Rep2024;14:12267 PMCID:PMC11133306

[37] Shi G,Wang J.Isolation of extracellular outer membrane vesicles (OMVs) from Escherichia coli using EVscore47 beads.Molecules2024;29:1831 PMCID:PMC11054804

[38] Moccia V,Giusti I.Isolation and characterization of cetacean cell-derived extracellular vesicles.Animals2023;13:3304 PMCID:PMC10650552

[39] Lee Y,Wasinger VC,Li Y.Comparison study of small extracellular vesicle isolation methods for profiling protein biomarkers in breast cancer liquid biopsies.Int J Mol Sci2023;24:15462 PMCID:PMC10607056

[40] Ciliberti MG,Sevi A.First insight into extracellular vesicle-miRNA characterization in a sheep in vitro model of inflammation.Front Vet Sci2023;10:1186989 PMCID:PMC10703394

[41] Vo N,Tran NHB.A novel multi-stage enrichment workflow and comprehensive characterization for HEK293F-derived extracellular vesicles.J Extracell Vesicles2024;13:e12454 PMCID:PMC11101607

[42] Visan KS,Ham S.Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles.J Extracell Vesicles2022;11:e12266 PMCID:PMC9486818

[43] Mansur S,Hawkins M,Weinman ST.Preparation of nanoparticle-loaded extracellular vesicles using direct flow filtration.Pharmaceutics2023;15:1551 PMCID:PMC10221999

[44] Li Z,Cheng Y.Cascaded microfluidic circuits for pulsatile filtration of extracellular vesicles from whole blood for early cancer diagnosis.Sci Adv2023;9:eade2819 PMCID:PMC10121168

[45] Sunkara V,Han J.Exosome precipitation by ionic strength modulation: ExoPRISM.ACS Appl Mater Interfaces2023;15:56807-19 PMCID:PMC10726304

[46] Morozumi M,Shimizu T.Comparison of isolation methods using commercially available kits for obtaining extracellular vesicles from cow milk.J Dairy Sci2021;104:6463-71

[47] Mladenović D,Kittel Á,Buzás EI.Acidification of blood plasma facilitates the separation and analysis of extracellular vesicles.J Thromb Haemost2023;21:1032-42

[48] Zhang Z,You Y.Comprehensive characterization of human brain-derived extracellular vesicles using multiple isolation methods: implications for diagnostic and therapeutic applications.J Extracell Vesicles2023;12:e12358 PMCID:PMC10415636

[49] Williams S,Lewis MP.A survey to evaluate parameters governing the selection and application of extracellular vesicle isolation methods.J Tissue Eng2023;14:20417314231155114 PMCID:PMC9996742

[50] Vychytilova-Faltejskova P,Pifkova L.Optimized procedure for high-throughput transcriptome profiling of small extracellular vesicles isolated from low volume serum samples.Clin Chem Lab Med2024;62:157-67

[51] Tengler L,Schütz J.Optimization of extracellular vesicles preparation from saliva of head and neck cancer patients.Sci Rep2024;14:946 PMCID:PMC10781729

[52] Soupir AC,Stewart PA.Detectable lipidomes and metabolomes by different plasma exosome isolation methods in healthy controls and patients with advanced prostate and lung cancer.Int J Mol Sci2023;24:1830 PMCID:PMC9916336

[53] Soares M,Nobre RJ.Isolation of extracellular vesicles from human follicular fluid: size-exclusion chromatography versus ultracentrifugation.Biomolecules2023;13:278 PMCID:PMC9953485

[54] Northrop-Albrecht EJ,Huang BQ,Lucien F.Assessment of extracellular vesicle isolation methods from human stool supernatant.J Extracell Vesicles2022;11:e12208 PMCID:PMC8980777

[55] Martínez-Greene JA,Ramos-Godínez MDP.Isolation of hepatic and adipose-tissue-derived extracellular vesicles using density gradient separation and size exclusion chromatography.Int J Mol Sci2023;24:12704 PMCID:PMC10454538

[56] Zhang C,Zhu Y.Electrodeposited magnetic nanoporous membrane for high-yield and high-throughput immunocapture of extracellular vesicles and lipoproteins.Commun Biol2022;5:1358 PMCID:PMC9741596

[57] Yang K,Cheddah S.Peptide ligand-SiO₂ microspheres with specific affinity for phosphatidylserine as a new strategy to isolate exosomes and application in proteomics to differentiate hepatic cancer.Bioact Mater2022;15:343-54 PMCID:PMC8935132

[58] Guo X,Zhao S,Zhang Z.Immunomagnetic separation method integrated with the Strep-tag II system for rapid enrichment and mild release of exosomes.Anal Chem2023;95:3569-76

[59] Fortunato D,Giménez-Capitán A,Molina-Vila MA.Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies.Biomark Res2022;10:57 PMCID:PMC9357340

[60] Colella AP,Miklavcic JJ.Homogenization and thermal processing reduce the concentration of extracellular vesicles in bovine milk.Food Sci Nutr2024;12:131-40 PMCID:PMC10804120

[61] Hartung F,Schindela S.Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID-exacerbated respiratory disease.Allergy2024;79:1893-907

[62] Yung C,Kuhn M.Neonatal enteroids absorb extracellular vesicles from human milk-fed infant digestive fluid.J Extracell Vesicles2024;13:e12422 PMCID:PMC11007820

[63] Fan W,Zhang J.Naringenin regulates cigarette smoke extract-induced extracellular vesicles from alveolar macrophage to attenuate the mouse lung epithelial ferroptosis through activating EV miR-23a-3p/ACSL4 axis.Phytomedicine2024;124:155256

[64] Hallal SM,Sida LA.Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a ‘liquid gold’ biopsy.Br J Cancer2024;130:836-51 PMCID:PMC10912426

[65] Pait MC,Su Y.Novel method for collecting hippocampal interstitial fluid extracellular vesicles (EV(ISF) ) reveals sex-dependent changes in microglial EV proteome in response to Aβ pathology.J Extracell Vesicles2024;13:e12398 PMCID:PMC10029004

[66] Tominaga Y,Ito E.Pleiotropic effects of extracellular vesicles from induced pluripotent stem cell-derived cardiomyocytes on ischemic cardiomyopathy: a preclinical study.J Heart Lung Transplant2024;43:85-99

[67] Kawano K,Yoshio K.Extracellular-vesicle catch-and-release isolation system using a net-charge invertible curvature-sensing peptide.Anal Chem2024;96:3754-62

[68] Mishra A,Bharti PK.Spectroscopic insight into breast cancer: profiling small extracellular vesicles lipids via infrared spectroscopy for diagnostic precision.Sci Rep2024;14:9347 PMCID:PMC11039614

[69] Pecksen E,Schröder C.Monocytes prevent apoptosis of iPSCs and promote differentiation of kidney organoids.Stem Cell Res Ther2024;15:132 PMCID:PMC11069262

[70] Matchett EC.Extracellular vesicles derived from immortalized human natural killer cell line NK3.3 as a novel therapeutic for multiple myeloma.Front Immunol2023;14:1265101 PMCID:PMC10560732

[71] Livkisa D,Burnouf T.Extracellular vesicles purified from serum-converted human platelet lysates offer strong protection after cardiac ischaemia/reperfusion injury.Biomaterials2024;306:122502

[72] Koksal AR,Aydin Y.A single-step immunocapture assay to quantify HCC exosomes using the highly sensitive fluorescence nanoparticle-tracking analysis.J Hepatocell Carcinoma2023;10:1935-54 PMCID:PMC10627088

[73] Wang Z,He H.Cellulose nanofibrils of high immunoaffinity for efficient enrichment of small extracellular vesicles.Small Methods2024;8:e2400426 PMCID:PMC11579556

[74] Kaur M,Van den Broek B.Most recent advances and applications of extracellular vesicles in tackling neurological challenges.Med Res Rev2024;44:1923-66

[75] Hanson B,Zheng W.EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method.Mol Ther Nucleic Acids2023;33:511-28 PMCID:PMC10432918

[76] Zheng T,Liu Q.Effect of extracelluar vesicles derived from Akkermansia muciniphila on intestinal barrier in colitis mice.Nutrients2023;15:4722 PMCID:PMC10674789

[77] Yang Z,Rao J.Mesenchymal stem cell-derived extracellular vesicles therapy in traumatic central nervous system diseases: a systematic review and meta-analysis.Neural Regen Res2023;18:2406-12 PMCID:PMC10360088

[78] de Pedro MÁ,González-Nuño FM.Menstrual blood-derived mesenchymal stromal cells: impact of preconditioning on the cargo of extracellular vesicles as potential therapeutics.Stem Cell Res Ther2023;14:187 PMCID:PMC10386225

[79] Bathini S,Ouellette RJ,Packirisamy M.Magnetic particle based liquid biopsy chip for isolation of extracellular vesicles and characterization by gene amplification.Biosens Bioelectron2021;194:113585

[80] Chattrairat K,Suzuki S.All-in-one nanowire assay system for capture and analysis of extracellular vesicles from an ex vivo brain tumor model.ACS Nano2023;17:2235-44 PMCID:PMC9933609

[81] Zhang T,Zheng X.CRISPR-Cas12a powered hybrid nanoparticle for extracellular vesicle aggregation and in-situ microRNA detection.Biosens Bioelectron2024;245:115856

[82] Zhou X,Wang Y.Tumour-derived extracellular vesicle membrane hybrid lipid nanovesicles enhance siRNA delivery by tumour-homing and intracellular freeway transportation.J Extracell Vesicles2022;11:e12198 PMCID:PMC8888792

[83] Liu Q,Pan X.Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification.J Nanobiotechnology2023;21:334 PMCID:PMC10505332

[84] Hao D,Song H.Engineered extracellular vesicles with high collagen-binding affinity present superior in situ retention and therapeutic efficacy in tissue repair.Theranostics2022;12:6021-37 PMCID:PMC9373818

[85] Fei Z,Zheng X,Liu G.Engineering extracellular vesicles for diagnosis and therapy.Trends Pharmacol Sci2024;45:931-40

[86] Ma Y,Williams GR.Extracellular vesicle-embedded materials.J Control Release2023;361:280-96

[87] Alvarez-Erviti L,Yin H,Lakhal S.Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes.Nat Biotechnol2011;29:341-5

[88] Tian Y,Song J.A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.Biomaterials2014;35:2383-90

[89] Farahani MS,Moazzeni SM.Engineered extracellular vesicles expressing ICAM-1: a promising targeted delivery system for T cell modifications.Biochim Biophys Acta Gen Subj2024;1868:130541

[90] Cheng Q,Han M,Lenz HJ.Reprogramming exosomes as nanoscale controllers of cellular immunity.J Am Chem Soc2018;140:16413-7 PMCID:PMC6469991

[91] Shi X,Hou T.Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy.Mol Ther2020;28:536-47 PMCID:PMC7001084

[92] Liang G,Zhu Y,Feng W.Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells.Int J Nanomedicine2018;13:585-99 PMCID:PMC5796471

[93] Ran N,Dong X.Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice.Biomaterials2020;236:119826

[94] Nonaka T.Application of engineered extracellular vesicles to overcome drug resistance in cancer.Front Oncol2022;12:1070479 PMCID:PMC9797956

[95] Johnson V,Kumar US.Surface-engineered extracellular vesicles in cancer immunotherapy.Cancers2023;15:2838 PMCID:PMC10216164

[96] Mohammadi AH,Bagheri F,Baghaei K.Modification of extracellular vesicle surfaces: an approach for targeted drug delivery.BioDrugs2023;37:353-74

[97] Wu P,Ocansey DKW,Qian H.Extracellular vesicles: a bright star of nanomedicine.Biomaterials2021;269:120467

[98] Tian T,He CP.Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy.Biomaterials2018;150:137-49

[99] S S,Dahal S.Surface-functionalized stem cell-derived extracellular vesicles for vascular elastic matrix regenerative repair.Mol Pharm2023;20:2801-13 PMCID:PMC10249416

[100] Nie W,Zhang J.Responsive exosome nano-bioconjugates for synergistic cancer therapy.Angew Chem Int Ed Engl2020;59:2018-22

[101] Liu HM.Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.Kaohsiung J Med Sci2024;40:435-44

[102] Kooijmans SAA,van der Meel R.PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.J Control Release2016;224:77-85

[103] Kooijmans SA,Roffler SR,Vader P.Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting.J Extracell Vesicles2016;5:31053 PMCID:PMC4793259

[104] Wang Y,Tian B.Nucleolin-targeted extracellular vesicles as a versatile platform for biologics delivery to breast cancer.Theranostics2017;7:1360-72 PMCID:PMC5399599

[105] Royo F,Ruiz de Angulo A,Falcon-Perez JM.Modification of the glycosylation of extracellular vesicles alters their biodistribution in mice.Nanoscale2019;11:1531-7

[106] Shou J,Shi W.3WJ RNA nanoparticles-aptamer functionalized exosomes from M2 macrophages target BMSCs to promote the healing of bone fractures.Stem Cells Transl Med2023;12:758-74 PMCID:PMC10630079

[107] Nakase I.Combined treatment with a pH-sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes.Sci Rep2015;5:10112 PMCID:PMC4443764

[108] Huang T,Kuramochi A.Surface modulation of extracellular vesicles with cell-penetrating peptide-conjugated lipids for improvement of intracellular delivery to endothelial cells.Regen Ther2023;22:90-8 PMCID:PMC9842955

[109] Lin SW,Shyong YJ.Drug delivery of extracellular vesicles: preparation, delivery strategies and applications.Int J Pharm2023;642:123185

[110] Zheng D,Chen W.Advances in extracellular vesicle functionalization strategies for tissue regeneration.Bioact Mater2023;25:500-26 PMCID:PMC10087114

[111] Roerig J.Standardization approaches for extracellular vesicle loading with oligonucleotides and biologics.Small2023;19:e2301763

[112] Chen C,Wang Q,Wu L.Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles.Anal Bioanal Chem2023;415:1287-98

[113] Song J,Yuan L.Multiplexed strategies toward clinical translation of extracellular vesicles.Theranostics2022;12:6740-61 PMCID:PMC9516239

[114] Chandler K,Ward G.Imaging of light-enhanced extracellular vesicle-mediated delivery of oxaliplatin to colorectal cancer cells via laser ablation, inductively coupled plasma mass spectrometry.Cells2023;13:24 PMCID:PMC10778274

[115] Sancho-Albero M,Beltrán-Visiedo M.Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids.Nanoscale2019;11:18825-36

[116] Faruque H, Choi ES, Kim JH, Kim E. Enhanced effect of autologous EVs delivering paclitaxel in pancreatic cancer.J Control Release2022;347:330-46

[117] Yang X,Guo J,He Y.Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus.Int J Nanomedicine2018;13:8095-104 PMCID:PMC6278838

[118] Chen SY,Li PC.Engineered extracellular vesicles carrying let-7a-5p for alleviating inflammation in acute lung injury.J Biomed Sci2024;31:30 PMCID:PMC10949767

[119] Zhang Y,Chopp M.Small extracellular vesicles derived from cerebral endothelial cells with elevated microRNA 27a promote ischemic stroke recovery.Neural Regen Res2025;20:224-33 PMCID:PMC11246145

[120] Qu M,Wang X,Zhou L.Palmitoylation of vacuole membrane protein 1 promotes small extracellular vesicle secretion via interaction with ALIX and influences intercellular communication.Cell Commun Signal2024;22:150 PMCID:PMC10895845

[121] Nebogatova J,Puskar A.A method for using cell-penetrating peptides for loading plasmid DNA into secreted extracellular vesicles.Biomolecules2023;13:1751 PMCID:PMC10741998

[122] Zou A,Chi B.Engineered exosomes with growth differentiation factor-15 overexpression enhance cardiac repair after myocardial injury.Int J Nanomedicine2024;19:3295-314 PMCID:PMC11007405

[123] Wu Y,Shi X.Myeloma extracellular vesicle-derived RAGE increases inflammatory responses and myotube atrophy in multiple myeloma through activation of the TLR4/NF-κB p65 pathway.Apoptosis2024;29:849-64

[124] Chiang CL,Hou YC.Dual targeted extracellular vesicles regulate oncogenic genes in advanced pancreatic cancer.Nat Commun2023;14:6692 PMCID:PMC10593751

[125] Wang X,Zhu D,Cheng K.Comparison of extruded cell nanovesicles and exosomes in their molecular cargos and regenerative potentials.Nano Res2023;16:7248-59 PMCID:PMC9971669

[126] Sun L,Huang D.Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug delivery to pulmonary fibrosis.Biomaterials2021;271:120761

[127] Zhang W,Guo H,Huang X.Dapagliflozin-loaded exosome mimetics facilitate diabetic wound healing by HIF-1α-mediated enhancement of angiogenesis.Adv Healthc Mater2023;12:e2202751 PMCID:PMC11469070

[128] Zhang L,Hao W.NSCs migration promoted and drug delivered exosomes-collagen scaffold via a bio-specific peptide for one-step spinal cord injury repair.Adv Healthc Mater2021;10:e2001896

[129] Fu P,Luo Y.Visualization of microRNA therapy in cancers delivered by small extracellular vesicles.J Nanobiotechnology2023;21:457 PMCID:PMC10685536

[130] Du J,Wang C.Designer exosomes for targeted and efficient ferroptosis induction in cancer via chemo-photodynamic therapy.Theranostics2021;11:8185-96 PMCID:PMC8344009

[131] Wang P,Huang Q.Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation.Theranostics2019;9:1714-27 PMCID:PMC6485189

[132] Haney MJ,Harrison EB,Kabanov AV.TPP1 delivery to lysosomes with extracellular vesicles and their enhanced brain distribution in the animal model of batten disease.Adv Healthc Mater2019;8:e1801271 PMCID:PMC6584948

[133] Wu C,Wang H.Orally deliverable sequence-targeted fucoxanthin-loaded biomimetic extracellular vesicles for alleviation of nonalcoholic fatty liver disease.ACS Appl Mater Interfaces2024;16:9854-67

[134] Lee C,Park J,Clarissa EM.Tonicity-induced cargo loading into extracellular vesicles.Lab Chip2024;24:2069-79

[135] Santos NL,Reis PP,Andrade LNS.Extracellular vesicle-packaged miR-195-5p sensitizes melanoma to targeted therapy with kinase inhibitors.Cells2023;12:1317 PMCID:PMC10177607

[136] Draguet F,Bouland C.Extracellular vesicles derived from human umbilical cord mesenchymal stromal cells as an efficient nanocarrier to deliver siRNA or drug to pancreatic cancer cells.Cancers2023;15:2901 PMCID:PMC11475828

[137] Kammala AK,Radnaa E.Extracellular vesicles-mediated recombinant IL-10 protects against ascending infection-associated preterm birth by reducing fetal inflammatory response.Front Immunol2023;14:1196453 PMCID:PMC10437065

[138] Rabienezhad Ganji N,Tinnirello V.Proof-of-concept study on the use of tangerine-derived nanovesicles as siRNA delivery vehicles toward colorectal cancer cell line SW480.Int J Mol Sci2023;25:546 PMCID:PMC10779162

[139] Rong Y,Tang P.Engineered extracellular vesicles for delivery of siRNA promoting targeted repair of traumatic spinal cord injury.Bioact Mater2023;23:328-42 PMCID:PMC9706413

[140] Liu W,Li X.Dual-engineered cartilage-targeting extracellular vesicles derived from mesenchymal stem cells enhance osteoarthritis treatment via miR-223/NLRP3/pyroptosis axis: toward a precision therapy.Bioact Mater2023;30:169-83 PMCID:PMC10429745

[141] Zhang S,Ji P.Truncated PD1 engineered gas-producing extracellular vesicles for ultrasound imaging and subsequent degradation of PDL1 in tumor cells.Adv Sci2024;11:e2305891 PMCID:PMC10966533

[142] Zhu S,Liu D,Shen L.Augmented cellular uptake and homologous targeting of exosome-based drug loaded IOL for posterior capsular opacification prevention and biosafety improvement.Bioact Mater2022;15:469-81 PMCID:PMC8958386

[143] Wu G,Zhao Q.Molecularly engineered macrophage-derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment.Angew Chem Int Ed Engl2020;59:4068-74

[144] Lennaárd AJ,Wiklander RJ,Wiklander OPB.Optimised electroporation for loading of extracellular vesicles with doxorubicin.Pharmaceutics2021;14:38 PMCID:PMC8780628

[145] Pan X, Huang P, Ali SS, et al. CRISPR-Cas9 engineered extracellular vesicles for the treatment of dominant progressive hearing loss. bioRxiv 2023. Available from https://www.biorxiv.org/content/10.1101/2023.09.14.557853v2 [accessed 12 December 2024].

[146] Dumontel B,Limongi T.Nanotechnological engineering of extracellular vesicles for the development of actively targeted hybrid nanodevices.Cell Biosci2022;12:61 PMCID:PMC9107671

[147] Zattoni IF,Dutra JP.Targeting breast cancer resistance protein (BCRP/ABCG2): functional inhibitors and expression modulators.Eur J Med Chem2022;237:114346

[148] Zhang L,Wang Q.The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer.Mol Cancer2020;19:10 PMCID:PMC6966863

[149] Zhang L,Hu C.CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.Mol Cancer2022;21:103 PMCID:PMC9027122

[150] Dakhlaoui I,Maalej E.Synthesis and biological assessment of new pyrimidopyrimidines as inhibitors of breast cancer resistance protein (ABCG2).Bioorg Chem2021;116:105326

[151] Goebel J,Hrycyna CA.The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors.Cancer Drug Resist2021;4:784-804 PMCID:PMC8730335

[152] Zhang H,Ashby CR Jr,Chen ZS.Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).Med Res Rev2021;41:525-55

[153] da Silva Zanzarini I,Scheiffer G.Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2).Bioorg Chem2024;146:107283 PMCID:PMC11069345

[154] Puris E,Gynther M.The role of solute carrier transporters in efficient anticancer drug delivery and therapy.Pharmaceutics2023;15:364 PMCID:PMC9966068

[155] Brouwer KLR,Hayden E.Regulation of drug transport proteins-from mechanisms to clinical impact: a white paper on behalf of the international transporter consortium.Clin Pharmacol Ther2022;112:461-84 PMCID:PMC9398928

[156] Zhou S.Transcriptional regulation of solute carrier (SLC) drug transporters.Drug Metab Dispos2022;50:1238-50 PMCID:PMC9488976

[157] Huttunen J,Järvinen J,Markowicz-Piasecka M.Amino acid derivative of probenecid potentiates apoptosis-inducing effects of vinblastine by increasing oxidative stress in a cancer cell-specific manner.Chem Biol Interact2024;388:110833

[158] Oh JM.Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS.Theranostics2021;11:6251-77 PMCID:PMC8120202

[159] Ullmann TM,Moore MD.Dual inhibition of BRAF and MEK increases expression of sodium iodide symporter in patient-derived papillary thyroid cancer cells in vitro.Surgery2020;167:56-63

[160] Ogiwara H,Sasaki M.Targeting the vulnerability of glutathione metabolism in ARID1A-deficient cancers.Cancer Cell2019;35:177-90.e8

[161] Momparler RL.Biochemical pharmacology of cytosine arabinoside.Med Pediatr Oncol1982;10 Suppl 1:45-8

[162] Kawahara B,Janzen C.Carbon monoxide inhibits cytochrome P450 enzymes CYP3A4/2C8 in human breast cancer cells, increasing sensitivity to paclitaxel.J Med Chem2021;64:8437-46

[163] Hachey AC,Heidary DK.Design of cytochrome P450 1B1 inhibitors via a scaffold-hopping approach.J Med Chem2023;66:398-412

[164] Hu C,Zou F.Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy.Acta Pharm Sin B2023;13:3694-707 PMCID:PMC10502288

[165] Meng S,Wang J.Systematic analysis of tyrosine kinase inhibitor response to RET gatekeeper mutations in thyroid cancer.Mol Inform2016;35:495-505

[166] Hanker AB,Meiler J.Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.Cancer Cell2021;39:1099-114.e8 PMCID:PMC8355076

[167] Zhao S,Pan H.Conformational landscapes of HER2 Exon 20 insertions explain their sensitivity to kinase inhibitors in lung adenocarcinoma.J Thorac Oncol2020;15:962-72

[168] Wood KC.Mapping the pathways of resistance to targeted therapies.Cancer Res2015;75:4247-51 PMCID:PMC4609261

[169] Wang D,Gao L.Increased IRF9-STAT2 signaling leads to adaptive resistance toward targeted therapy in melanoma by restraining GSDME-dependent pyroptosis.J Invest Dermatol2022;142:2476-87.e9

[170] Kobayashi Y,Yamaguchi H.Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer.Semin Cancer Biol2020;65:51-64

[171] Klener P,Renesova N.BH3 mimetics in hematologic malignancies.Int J Mol Sci2021;22:10157 PMCID:PMC8466478

[172] Marelli M, Beretta G, Moretti RM. Necroptosis induced by delta-tocotrienol overcomes docetaxel chemoresistance in prostate cancer cells.Int J Mol Sci2023;24:4923 PMCID:PMC10003232

[173] Shi ZD,Wu ZX.Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies.Signal Transduct Target Ther2023;8:113 PMCID:PMC10008648

[174] Yang C,Zhang J.EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.Proc Natl Acad Sci U S A2024;121:e2317790121 PMCID:PMC11161775

[175] Qin S,Yi M,Wu K.Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.Mol Cancer2019;18:155 PMCID:PMC6833286

[176] Wang H,Wei J.Beta2-microglobulin(B2M) in cancer immunotherapies: biological function, resistance and remedy.Cancer Lett2021;517:96-104

[177] Lin W,Zhang H.Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation.Nat Commun2023;14:265 PMCID:PMC9845301

[178] Joung J,Singh A.CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.Nat Commun2022;13:1606 PMCID:PMC8956604

[179] Zhong F,Zhao L,Ye Y.Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics.Br J Cancer2023;129:24-37 PMCID:PMC10307880

[180] Lorenzo-Sanz L,da Silva-Diz V.Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma.Nat Commun2024;15:5352 PMCID:PMC11196727

[181] Guelfi S,Bergers G.Targeting the tumour vasculature: from vessel destruction to promotion.Nat Rev Cancer2024;24:655-75

[182] Sattiraju A,Giotti B.Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression.Immunity2023;56:1825-43.e6 PMCID:PMC10527169

[183] Zhang T,Yu Y,Xu F.Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy.Adv Drug Deliv Rev2022;186:114319

[184] Goswami S,Raychaudhuri D.Myeloid cell-targeted therapies for solid tumours.Nat Rev Immunol2023;23:106-20

[185] Li N,Wang L.ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.Proc Natl Acad Sci U S A2020;117:20159-70 PMCID:PMC7443867

[186] Chow A,Klebanoff CA.Clinical implications of T cell exhaustion for cancer immunotherapy.Nat Rev Clin Oncol2022;19:775-90 PMCID:PMC10984554

[187] Andrews LP,Cui J.LAG-3 and PD-1 synergize on CD8⁺ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity.Cell2024;187:4355-72.e22 PMCID:PMC11323044

[188] Aspe JR,Jutzy JM,Whang S.Enhancement of Gemcitabine sensitivity in pancreatic adenocarcinoma by novel exosome-mediated delivery of the Survivin-T34A mutant.J Extracell Vesicles2014;3 PMCID:PMC3929070

[189] Lou G,Xia C.MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway.J Exp Clin Cancer Res2020;39:4 PMCID:PMC6941283

[190] Xu Y,Wei Y.Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells.Aging2020;12:19660-76 PMCID:PMC7732307

[191] Jia Z,Sun H.Adipose mesenchymal stem cell-derived exosomal microRNA-1236 reduces resistance of breast cancer cells to cisplatin by suppressing SLC9A1 and the Wnt/β-catenin signaling.Cancer Manag Res2020;12:8733-44 PMCID:PMC7519869

[192] Qiu L,Chen M,Tu W.Exosomal microRNA-146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane via a LAMC2-mediated PI3K/Akt axis.Int J Mol Med2020;46:609-20 PMCID:PMC7307828

[193] Wu H,Liu L.Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells via targeting LRRC1.Cell Death Dis2020;11:801 PMCID:PMC7519084

[194] Munoz JL,Greco SJ,Ligon KL.Delivery of functional anti-miR-9 by mesenchymal stem cell-derived exosomes to glioblastoma multiforme cells conferred chemosensitivity.Mol Ther Nucleic Acids2013;2:e126 PMCID:PMC4027430

[195] Yu L,Liu Y.Exosomes derived from microRNA-199a-overexpressing mesenchymal stem cells inhibit glioma progression by down-regulating AGAP2.Aging2019;11:5300-18 PMCID:PMC6710058

[196] Sharif S,Soleimani M.Delivery of exogenous miR-124 to glioblastoma multiform cells by wharton’s jelly mesenchymal stem cells decreases cell proliferation and migration, and confers chemosensitivity.Stem Cell Rev Rep2018;14:236-46

[197] Li P,Huang Y.siMTA1-loaded exosomes enhanced chemotherapeutic effect of gemcitabine in Luminal-b type breast cancer by inhibition of EMT/HIF-α and autophagy pathways.Front Oncol2020;10:541262 PMCID:PMC7691572

[198] Lin D,Liu R.iRGD-modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation.Mol Oncol2021;15:3430-46 PMCID:PMC8637580

[199] Zeng A,Yan W.Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.Cancer Lett2018;436:10-21

[200] Zhao Z,Gao Y.Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.Cancer Lett2022;530:45-58

[201] Wang X,Bai M.Exosomes serve as nanoparticles to deliver anti-miR-214 to reverse chemoresistance to cisplatin in gastric cancer.Mol Ther2018;26:774-83 PMCID:PMC5910674

[202] Ji R,Gu H.Mir-374a-5p: a new target for diagnosis and drug resistance therapy in gastric cancer.Mol Ther Nucleic Acids2019;18:320-31 PMCID:PMC6796712

[203] Sayyed AA,Mali M.MiR-155 inhibitor-laden exosomes reverse resistance to cisplatin in a 3D tumor spheroid and xenograft model of oral cancer.Mol Pharm2021;18:3010-25

[204] Bose RJC,Zeng Y.Tumor cell-derived extracellular vesicle-coated nanocarriers: an efficient theranostic platform for the cancer-specific delivery of anti-miR-21 and imaging agents.ACS Nano2018;12:10817-32 PMCID:PMC6684278

[205] Hui B,Wang J.Engineered exosomes for co-delivery of PGM5-AS1 and oxaliplatin to reverse drug resistance in colon cancer.J Cell Physiol2022;237:911-33

[206] Xu Y,Peng F,Wang J.Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p.Neoplasma2021;68:108-18

[207] Zhou Y,Chen X.Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer.Acta Pharm Sin B2020;10:1563-75 PMCID:PMC7488356

[208] Zhang X,Tang M,Guo X.The effects of umbilical cord-derived macrophage exosomes loaded with cisplatin on the growth and drug resistance of ovarian cancer cells.Drug Dev Ind Pharm2020;46:1150-62

[209] Li L,Guo Q.Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer.J Nanobiotechnology2022;20:50 PMCID:PMC8787930

[210] Liu J,Xiang M.Functional extracellular vesicles engineered with lipid-grafted hyaluronic acid effectively reverse cancer drug resistance.Biomaterials2019;223:119475

[211] Lv Q,Lu Y.Thermosensitive exosome-liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved treatment of metastatic peritoneal cancer.Adv Sci2020;7:2000515 PMCID:PMC7509655

[212] Liang G,Ali DJ.Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer.J Nanobiotechnology2020;18:10 PMCID:PMC6950820

[213] Kim MS,Zhao Y.Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.Nanomedicine2016;12:655-64 PMCID:PMC4809755

[214] Bellavia D,Calabrese G.Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous leukemia cell growth.Theranostics2017;7:1333-45 PMCID:PMC5399597

[215] Liu Y,Wei Y.Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway.Cytotherapy2018;20:181-8

[216] Li H,Shi Y.Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma.J Nanobiotechnology2018;16:103 PMCID:PMC6300915

[217] Xu J,Liang Y.CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1.Signal Transduct Target Ther2020;5:298 PMCID:PMC7762756

[218] Wu L,Li Y.Biomimetic nanocarriers guide extracellular ATP homeostasis to remodel energy metabolism for activating innate and adaptive immunity system.Adv Sci2022;9:e2105376 PMCID:PMC9189650

[219] Zhou W,Chen X.Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment.Biomaterials2021;268:120546

[220] Kurniawati I,Hsieh CL,Sung SY.Targeting castration-resistant prostate cancer using mesenchymal stem cell exosomes for therapeutic microRNA-let-7c delivery.Front Biosci2022;27:256

[221] Dauer P,Gupta VK.ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”.Cell Death Dis2019;10:132 PMCID:PMC6372649

[222] Kalbasi A.Tumour-intrinsic resistance to immune checkpoint blockade.Nat Rev Immunol2020;20:25-39 PMCID:PMC8499690

[223] Deng J.Overcoming the resistance of hepatocellular carcinoma to PD-1/PD-L1 inhibitor and the resultant immunosuppression by CD38 siRNA-loaded extracellular vesicles.Oncoimmunology2023;12:2152635 PMCID:PMC9809939

[224] Ranganathan P,Hiscox S,Vella V.Editorial: resistance to endocrine therapies in cancer.Front Endocrinol2020;11:196 PMCID:PMC7160226